Publisher's Synopsis
New medicines, new drug interaction data, the most recent side effects findings, and certain drugs now removed from the market make it critical for medical practitioners to keep up-to-date with the latest prescription drug information. Not only are today's prescription drugs vital to the patient's well-being, but their effectiveness and safety can impact the integrity and security of all healthcare professionals.;Topics covered in this edition include: details of current prescription drugs; how different drugs interact; findings on side effects caused by a prescribed drug; recommended dosages; clinical pharmacology; paediatric use; contraindications; and FDA use-in-pregnancy ratings. It includes information on over 4000 prescription drugs and data on more than 250 drug manufacturers.;Virtually all of the newly-approved drugs are covered in this edition: Rezulin, a new treatment option for diabetes; Posicor, the first T-channel blocker for hypertension and angina; Aricept, a new drug for Alzheimer's disease; Coreg, the first new approach to heart failure treatment; Lipitor and Baycol for hypercholesterolemia; and Flomax for benign prostatic hyperplasia. Many familiar drugs already on the market have had their prescribing information substantially amended with new warnings, adverse reactions and indications, as well as new uses.
